These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 20479655)
1. Successful reposition and treatment of severe aortic paraprosthetic regurgitation after percutaneous implantation of a self-expandable biological valve. Frerker C; Bergmann M; Schewel D; Busse C; Jensen F; Schmoeckel M; Schneider C; Kuck KH; Schaefer U J Cardiovasc Med (Hagerstown); 2012 May; 13(5):346-50. PubMed ID: 20479655 [No Abstract] [Full Text] [Related]
2. Aortic valve in valve insertion: a note of caution and a case for possible optimism. Dean LS Catheter Cardiovasc Interv; 2010 Dec; 76(7):1007-8. PubMed ID: 21108376 [No Abstract] [Full Text] [Related]
3. First trans-axillary implantation of Edwards Sapien valve to treat an incompetent aortic bioprosthesis. Sharp AS; Michev I; Colombo A Catheter Cardiovasc Interv; 2010 Mar; 75(4):507-10. PubMed ID: 20088013 [TBL] [Abstract][Full Text] [Related]
5. Procedural and clinical outcomes of the valve-in-valve technique for severe aortic insufficiency after balloon-expandable transcatheter aortic valve replacement. Giri J; Bortnick AE; Wallen T; Walsh E; Bannan A; Desai N; Szeto WY; Bavaria J; Herrmann HC Catheter Cardiovasc Interv; 2012 Jul; 80(1):139-47. PubMed ID: 22419611 [TBL] [Abstract][Full Text] [Related]
6. Correction of aortic regurgitation after transcatheter aortic valve implantation of the Medtronic CoreValveTM prosthesis due to a too-low implantation, using transcatheter repositioning. Zahn R; Schiele R; Kilkowski C; Klein B; Zeymer U; Werling C; Lehmann A; Gerckens U; Saggau W J Heart Valve Dis; 2011 Jan; 20(1):64-9. PubMed ID: 21404899 [TBL] [Abstract][Full Text] [Related]
7. Performance of valve-in-valve for severe para-prosthetic leaks due to inadequate transcatheter aortic valve implantation. Napodano M; Gasparetto V; Tarantini G; Fraccaro C; Yzeiraj E; Gerosa G; Isabella G; Iliceto S Catheter Cardiovasc Interv; 2011 Dec; 78(7):996-1003. PubMed ID: 22114036 [TBL] [Abstract][Full Text] [Related]
8. First-in-human valve-in-valve implantation of a 20 mm balloon expandable transcatheter heart valve. Binder RK; Wood D; Webb JG; Cheung A Catheter Cardiovasc Interv; 2013 Dec; 82(7):E929-31. PubMed ID: 22821872 [TBL] [Abstract][Full Text] [Related]
9. Severe intraprosthetic regurgitation and valve embolization after transcatheter aortic valve implantation. Ben-Dor I; Satler LF; Pichard AD; Waksman R Catheter Cardiovasc Interv; 2013 Feb; 81(2):392-6. PubMed ID: 22566389 [TBL] [Abstract][Full Text] [Related]
10. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation. Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664 [TBL] [Abstract][Full Text] [Related]
11. Difficulties with horizontal aortic root in transcatheter aortic valve implantation. Chan PH; Alegria-Barrero E; Di Mario C Catheter Cardiovasc Interv; 2013 Mar; 81(4):630-5. PubMed ID: 22431290 [TBL] [Abstract][Full Text] [Related]
12. Early experience of implantation of the new CoreValve(®) Evolut(™) in degenerated bioprosthetic aortic valves. Fairley SL; Jeganathan R; Manoharan G; Spence MS Catheter Cardiovasc Interv; 2014 Feb; 83(3):485-92. PubMed ID: 23857751 [TBL] [Abstract][Full Text] [Related]
14. Two-stage percutaneous closure of paravalvular leak in a patient with stentless aortic bioprosthesis. Smolka G; Pysz P; Jasinski M Catheter Cardiovasc Interv; 2013 Aug; 82(2):E119-23. PubMed ID: 22581510 [TBL] [Abstract][Full Text] [Related]
15. Transfemoral aortic valve-in-valve implantation with a balloon-expandable valve for the treatment of stentless xenograft severe aortic regurgitation. Bagur R; Rodés-Cabau J; De Larochellière R; Doyle D; Rheault M; Dumont E JACC Cardiovasc Interv; 2011 Nov; 4(11):1248-9. PubMed ID: 22115667 [No Abstract] [Full Text] [Related]
16. Transseptal approach for the management of paravalvular regurgitation after transcatheter aortic valve replacement. Martinez CA; O'Neill B; Singh V; O'Neill WW Catheter Cardiovasc Interv; 2013 Oct; 82(4):E587-91. PubMed ID: 23008182 [TBL] [Abstract][Full Text] [Related]
17. Treatment of a failing St. Jude Medical Trifecta by Medtronic Corevalve Evolut valve-in-valve implantation. Haussig S; Schuler G; Linke A JACC Cardiovasc Interv; 2014 Jul; 7(7):e81-2. PubMed ID: 24954575 [No Abstract] [Full Text] [Related]
18. Anatomic and procedural predictors of paravalvular aortic regurgitation after implantation of the Medtronic CoreValve bioprosthesis. Sherif MA; Abdel-Wahab M; Stöcker B; Geist V; Richardt D; Tölg R; Richardt G J Am Coll Cardiol; 2010 Nov; 56(20):1623-9. PubMed ID: 21050971 [TBL] [Abstract][Full Text] [Related]
20. Massive aortic regurgitation following paravalvular balloon valvuloplasty of an Edwards SAPIEN valve treated by emergent CoreValve implantation: never cross a transcatheter aortic valve without a pigtail. Noble S; Cikirikcioglu M; Roffi M Catheter Cardiovasc Interv; 2013 Oct; 82(4):E609-12. PubMed ID: 23460365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]